Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs139981268 | chr13:114160732 | TG/T | 4.56E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs139996278 | chr2:61503469 | TATAACTTC/T | 8.71E-5 | 174 | 21.95 | 30.93 | 10.3 | KM Plot |
PCPG | rs140036011 | chr2:118554034 | A/G | 1.89E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs140178951 | chr14:74569645 | CAT/C | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |
PCPG | rs140254258 | chr7:105164228 | G/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs140336573 | chr11:18145137 | G/T | 4.13E-6 | 175 | 27.23 | 23.82 | 6.37 | KM Plot |
PCPG | rs140360353 | chr13:54064471 | A/AT | 0.000258 | 176 | 25.47 | 20.47 | 3.17 | KM Plot |
PCPG | rs140402520 | chr9:136943003 | G/A | 5.12E-7 | 176 | 25.6 | 21.55 | 31.47 | KM Plot |
PCPG | rs140444739 | chr11:18149711 | G/A | 4.13E-6 | 175 | 27.2 | 23.53 | 10.3 | KM Plot |
PCPG | rs140488289 | chr12:56687459 | T/C | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs1405794 | chr3:39756531 | G/A | 8.3E-8 | 176 | 25.87 | 19.88 | 19.87 | KM Plot |
PCPG | rs140675793 | chr10:69732959 | T/TA | 0 | 175 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs1406780 | chr3:80570997 | A/G | 0.000292 | 178 | 27.2 | 24.77 | 19.2 | KM Plot |
PCPG | rs140776520 | chr16:89817299 | TTTGTTG/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs140844595 | chr2:24318837 | G/A | 0.000114 | 177 | 25.28 | 27.27 | 17.43 | KM Plot |